These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 27538418)

  • 1. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.
    Maillet A; Krack P; Lhommée E; Météreau E; Klinger H; Favre E; Le Bars D; Schmitt E; Bichon A; Pelissier P; Fraix V; Castrioto A; Sgambato-Faure V; Broussolle E; Tremblay L; Thobois S
    Brain; 2016 Sep; 139(Pt 9):2486-502. PubMed ID: 27538418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric Signs.
    Maillet A; Météreau E; Tremblay L; Favre E; Klinger H; Lhommée E; Le Bars D; Castrioto A; Prange S; Sgambato V; Broussolle E; Krack P; Thobois S
    Mov Disord; 2021 Dec; 36(12):2888-2900. PubMed ID: 34494685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging the Etiology of Apathy, Anxiety, and Depression in Parkinson's Disease: Implication for Treatment.
    Thobois S; Prange S; Sgambato-Faure V; Tremblay L; Broussolle E
    Curr Neurol Neurosci Rep; 2017 Aug; 17(10):76. PubMed ID: 28822071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
    Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
    Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limbic Serotonergic Plasticity Contributes to the Compensation of Apathy in Early Parkinson's Disease.
    Prange S; Metereau E; Maillet A; Klinger H; Schmitt E; Lhommée E; Bichon A; Lancelot S; Meoni S; Broussolle E; Castrioto A; Tremblay L; Krack P; Thobois S
    Mov Disord; 2022 Jun; 37(6):1211-1221. PubMed ID: 35238430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early limbic microstructural alterations in apathy and depression in de novo Parkinson's disease.
    Prange S; Metereau E; Maillet A; Lhommée E; Klinger H; Pelissier P; Ibarrola D; Heckemann RA; Castrioto A; Tremblay L; Sgambato V; Broussolle E; Krack P; Thobois S
    Mov Disord; 2019 Nov; 34(11):1644-1654. PubMed ID: 31309609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
    Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
    Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease.
    Ballanger B; Klinger H; Eche J; Lerond J; Vallet AE; Le Bars D; Tremblay L; Sgambato-Faure V; Broussolle E; Thobois S
    Mov Disord; 2012 Jan; 27(1):84-9. PubMed ID: 21994070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apathy and striatal dopamine defects in non-demented patients with Parkinson's disease.
    Chung SJ; Lee JJ; Ham JH; Lee PH; Sohn YH
    Parkinsonism Relat Disord; 2016 Feb; 23():62-5. PubMed ID: 26717857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
    Wilson H; Dervenoulas G; Pagano G; Koros C; Yousaf T; Picillo M; Polychronis S; Simitsi A; Giordano B; Chappell Z; Corcoran B; Stamelou M; Gunn RN; Pellecchia MT; Rabiner EA; Barone P; Stefanis L; Politis M
    Lancet Neurol; 2019 Aug; 18(8):748-759. PubMed ID: 31229470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Depressed" caudate and ventral striatum dopamine transporter availability in de novo Depressed Parkinson's disease.
    Yoo SW; Oh YS; Hwang EJ; Ryu DW; Lee KS; Lyoo CH; Kim JS
    Neurobiol Dis; 2019 Dec; 132():104563. PubMed ID: 31377233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction.
    Pavese N; Metta V; Bose SK; Chaudhuri KR; Brooks DJ
    Brain; 2010 Nov; 133(11):3434-43. PubMed ID: 20884645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonergic dysregulation is linked to sleep problems in Parkinson's disease.
    Wilson H; Giordano B; Turkheimer FE; Chaudhuri KR; Politis M
    Neuroimage Clin; 2018; 18():630-637. PubMed ID: 29845011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease.
    Picillo M; Santangelo G; Erro R; Cozzolino A; Amboni M; Vitale C; Barone P; Pellecchia MT
    Parkinsonism Relat Disord; 2017 Apr; 37():106-110. PubMed ID: 28214265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precuneus degeneration and isolated apathy in patients with Parkinson's disease.
    Shin JH; Shin SA; Lee JY; Nam H; Lim JS; Kim YK
    Neurosci Lett; 2017 Jul; 653():250-257. PubMed ID: 28579482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.
    Thobois S; Lhommée E; Klinger H; Ardouin C; Schmitt E; Bichon A; Kistner A; Castrioto A; Xie J; Fraix V; Pelissier P; Chabardes S; Mertens P; Quesada JL; Bosson JL; Pollak P; Broussolle E; Krack P
    Brain; 2013 May; 136(Pt 5):1568-77. PubMed ID: 23543483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separate neural representations of depression, anxiety and apathy in Parkinson's disease.
    Dan R; Růžička F; Bezdicek O; Růžička E; Roth J; Vymazal J; Goelman G; Jech R
    Sci Rep; 2017 Sep; 7(1):12164. PubMed ID: 28939804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression, anxiety, and apathy in Parkinson's disease: insights from neuroimaging studies.
    Wen MC; Chan LL; Tan LC; Tan EK
    Eur J Neurol; 2016 Jun; 23(6):1001-19. PubMed ID: 27141858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
    Wile DJ; Agarwal PA; Schulzer M; Mak E; Dinelle K; Shahinfard E; Vafai N; Hasegawa K; Zhang J; McKenzie J; Neilson N; Strongosky A; Uitti RJ; Guttman M; Zabetian CP; Ding YS; Adam M; Aasly J; Wszolek ZK; Farrer M; Sossi V; Stoessl AJ
    Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoaminergic Degeneration and Ocular Motor Abnormalities in De Novo Parkinson's Disease.
    Woo KA; Joun JH; Yoon EJ; Lee CY; Jeon B; Kim YK; Lee JY
    Mov Disord; 2023 Dec; 38(12):2291-2301. PubMed ID: 37846885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.